[Transurethral laser therapy of benign prostatic hyperplasia]

Area of Science:

• Urology
• Minimally Invasive Surgery
• Laser Therapeutics

Background:

• Benign prostatic hyperplasia (BPH) is a common condition causing obstructive urinary symptoms.
• Transurethral resection of the prostate (TURP) is a traditional surgical treatment for BPH.
• Transurethral laser therapy has emerged as a popular alternative in recent years.

Purpose of the Study:

• To evaluate the efficacy and safety of transurethral laser therapy for BPH.
• To compare laser therapy outcomes with traditional TURP.
• To determine the suitability of laser therapy for different patient risk groups.

Main Methods:

• Review of published clinical data on transurethral laser therapy for BPH.
• Comparison of efficacy and complication rates between laser therapy and TURP.
• Analysis of patient outcomes based on risk stratification.

Main Results:

• Transurethral laser therapy demonstrates efficacy in treating obstructive BPH symptoms.
• Laser therapy is associated with a significantly lower incidence of severe perioperative complications compared to TURP.
• Current data suggest laser therapy may be inferior to TURP in terms of therapeutic outcomes, though this requires further long-term evaluation.

Conclusions:

• Transurethral laser therapy is a viable treatment option for BPH, particularly for high-risk patients due to its favorable safety profile.
• The long-term efficacy of laser prostatectomy compared to TURP requires further investigation.
• The role of laser therapy in low-risk BPH patients remains undefined pending long-term follow-up data.